Patent US5057413A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5057413A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for discriminating between intact and damaged cells in a sample

Assignee: BECTON
•
Filing: 1988-06-13
•
Granted: 1991-10-15
•
Expires: 2008-06-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method is disclosed for the discrimination between intact and damaged cells in a sample, and more particularly, the method uses a vital nucleic acid dye to selectively stain intact versus damaged cells which then may be counted and sorted by flow cytometry means. The method also may be used in conjunction with fluorescently labelled mononclonal antibodies to simultaneously identify cellular antigens.

Inventors

  • 👤 Leon W. M. M. Terstappen
  • 👤 Michael R. Loken
  • 👤 Virendra O. Shah

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 16:53
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/02; G; G01; G01N; G01N15/00; G01N15/10; G01N15/14; G01N15/1456; G01N15/1459; G01N21/00; G01N21/62; G01N21/63; G01N21/64; G01N21/6428; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/569; G01N33/56966; G01N33/56972; G01N2015/1006; G01N2015/1402; G01N2015/1477; G01N2021/6439; Y; Y10; Y10S; Y10S436/00; Y10S436/80

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 227 words
A method for discriminating between a heterogeneous population of intact and damaged cells in a peripheral blood sample comprising the steps of: a) taking a sample of peripheral blood from an individual; b) adding to the sample one or more monoclonal antibodies to cell surface antigens, wherein the monoclonal antibodies are labeled with fluorescent labels and wherein the fluorescent labels have peak emission spectra that are distinguishable from each other and from a nucleic acid dye; c) adding a fixative to the sample; d) adding to the sample a nucleic acid dye which preferentially binds DNA, wherein the nucleic acid dye comprises the formula ##STR2## wherein n is 0; m is 1; R is a lower alkyl; R 1 and R 2 are lower alkyls; R 3 is hydrogen; Z is a quinoline nucleus which may be substituted with lower alkyl, halo, nitro, amino and dialkylamino; and X represents an anion; e) analyzing the sample in an automated instrument capable of passing the cells in the sample through a sensing region substantially one at a time and capable of detecting and recording both fluorescence and light scattered in more than one direction by each cell passing through said sensing region; and f) discriminating between damaged and intact cells in the sample based upon relative fluorescence intensity of the nucleic acid dye in each cell and light scattered.
Claim 2
Independent Claim 227 words
A method for discriminating between a heterogeneous population of intact and damaged cells in a peripheral blood sample comprising the steps of: a) taking a sample of peripheral blood from an individual; b) adding to the sample one or more monoclonal antibodies to cell surface antigens, wherein the monoclonal antibodies are labeled with fluorescent labels and wherein the fluorescent labels have peak emission spectra that are distinguishable from each other and from a nucleic acid dye; c) adding a fixative to the sample; d) adding to the sample a nucleic acid dye which preferentially binds DNA, wherein the nucleic acid dye comprises the formula ##STR2## wherein n is 0; m is 1; R is a lower alkyl; R 1 and R 2 are lower alkyls; R 3 is hydrogen; Z is a quinoline nucleus which may be substituted with lower alkyl, halo, nitro, amino and dialkylamino; and X represents an anion; e) analyzing the sample in an automated instrument capable of passing the cells in the sample through a sensing region substantially one at a time and capable of detecting and recording both fluorescence and light scattered in more than one direction by each cell passing through said sensing region; and f) discriminating between damaged and intact cells in the sample based upon relative fluorescence intensity of the nucleic acid dye in each cell and light scattered.
Claim 3
Dependent Claim 12 words
The method of claim 1 wherein erythrocytes in the sample are lysed.
Claim 4
Dependent Claim 13 words
The method of claim 1 wherein the automated instrument is a flow cytometer.
Claim 5
Dependent Claim 10 words
The method of claim 1 wherein the fixative is paraformaldehyde.
Claim 6
Dependent Claim 12 words
The method of claim 1 wherein the fluorescent label is fluorescein isothiocyanate.
Claim 7
Dependent Claim 11 words
The method of claim 1 wherein the fluorescent label is phycoerythrin.
Claim 8
Dependent Claim 14 words
The method of claim 1 wherein the fluorescent labels are fluorescein isothiocyanate and phycoerythrin.
Claim 9
Dependent Claim 25 words
The method of claim 1 wherein the intact and damaged cells are further discriminated based upon relative fluorescence intensity of fluorescent labels and light scattered.
Claim 10
Independent Claim 200 words
A method for discriminating between a heterogeneous population of intact and damaged cells in a peripheral blood sample comprising the steps of: a) taking a sample of peripheral blood from an individual; b) lysing erythrocytes in the sample; c) adding to the sample one or more monoclonal antibodies to cell surface antigens, wherein the monoclonal antibodies are labeled with fluorescent labels and wherein the fluorescent labels have peak emission spectra that are distinguishable from each other and from a nucleic acid dye; d) adding paraformaldehyde to the sample; e) adding to the sample a nucleic acid dye which preferentially binds DNA, wherein the nucleic acid dye comprises the formula ##STR3## wherein n is 0; m is 1; R is a lower alkyl; R 1 and R 2 are lower alkyls; R 3 is hydrogen; Z is a quinoline nucleus which may be substituted with lower alkyl, halo, nitro, amino and dialkylamino; and X represents an anion; e) analyzing said sample in a flow cytometer equipped with a single laser tuned to 488 nm; and f) discriminating between damaged and intact cells in the sample based upon relative fluorescence intensity of the nucleic acid dye in each cell and light scattered.
Claim 11
Independent Claim 200 words
A method for discriminating between a heterogeneous population of intact and damaged cells in a peripheral blood sample comprising the steps of: a) taking a sample of peripheral blood from an individual; b) lysing erythrocytes in the sample; c) adding to the sample one or more monoclonal antibodies to cell surface antigens, wherein the monoclonal antibodies are labeled with fluorescent labels and wherein the fluorescent labels have peak emission spectra that are distinguishable from each other and from a nucleic acid dye; d) adding paraformaldehyde to the sample; e) adding to the sample a nucleic acid dye which preferentially binds DNA, wherein the nucleic acid dye comprises the formula ##STR3## wherein n is 0; m is 1; R is a lower alkyl; R 1 and R 2 are lower alkyls; R 3 is hydrogen; Z is a quinoline nucleus which may be substituted with lower alkyl, halo, nitro, amino and dialkylamino; and X represents an anion; e) analyzing said sample in a flow cytometer equipped with a single laser tuned to 488 nm; and f) discriminating between damaged and intact cells in the sample based upon relative fluorescence intensity of the nucleic acid dye in each cell and light scattered.
Claim 12
Dependent Claim 25 words
The method of claim 9 wherein the intact and damaged cells are further discriminated based upon relative fluorescence intensity of fluorescent labels and light scattered.

References Cited (Backward Citations)

US3826364A Cited
US3826364B1 Cited
US4094745A Cited
US4284412A Cited
US4544546A Cited
US4520110A Cited
EP0121262A2 Cited
US4585736A Cited
US4661913A Cited
US4727020A Cited
EP0212455A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-10-14 1995-04-15 1995-10-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-10-14 1999-04-15 1999-10-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-10-14 2003-04-15 2003-10-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag